Paladin Labs Articles

Paladin gets certain rights to Immuron’s Travelan in up to C$117 million deal

30 November 2011

Battle for Afexa escalates as suitors Valeant and Paladin up offers; Dr Reddy’s and JBCPL scrap Russian deal

27 September 2011

Valeant out-bids Paladin with C$76 million cash bid for Afexa

31 August 2011

Paladin Labs to buy troubled Labopharm in $20.6 million deal

22 August 2011

Paladin buys ex-US rights to Somaxon’s insomnia drug Silenor for up to $129 million

13 June 2011

Paladin gets $1 million in amended deal with Isotechnika; acquires Tempra from for Canada

4 February 2011

ProStrakan agrees refinancing and distribution deal with Paladin Labs

20 December 2010

Canadian drugmakers Labopharm and Paladin expand commercial relationship

15 October 2010

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end